Milestone Pharmaceuticals Inc. - Common Shares (MIST)

CUSIP: 59935V107

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Shares
Shares outstanding
124,031,000
Total 13F shares
23,737,827
Share change
+1,996,393
Total reported value
$94,006,246
Put/Call ratio
2.1%
Price per share
$3.96
Number of holders
55
Value change
-$28,853,317
Number of buys
39
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 59935V107?
CUSIP 59935V107 identifies MIST - Milestone Pharmaceuticals Inc. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MIST - Milestone Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RTW INVESTMENTS, LP
13F
Company
3.5%
4,315,102
$39,656,000 30 Sep 2022
13F
VR Adviser, LLC
13F
Company
2%
2,425,737
$22,293,000 30 Sep 2022
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
1.8%
2,246,503
$20,645,000 30 Sep 2022
13F
Novo Holdings A/S
13F
Company
1.6%
2,000,000
$18,380,000 30 Sep 2022
13F
MORGAN STANLEY
13F
Company
1%
1,240,273
$11,398,000 30 Sep 2022
13F
Lion Point Capital, LP
13F
Company
1.3%
1,557,233
$11,186,000 30 Sep 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.75%
933,098
$8,575,000 30 Sep 2022
13F
Ikarian Capital, LLC
13F
Company
0.69%
855,616
$7,863,000 30 Sep 2022
13F
Boxer Capital, LLC
13F
Company
0.56%
698,861
$6,423,000 30 Sep 2022
13F
GREAT POINT PARTNERS LLC
13F
Company
0.54%
674,656
$6,200,000 30 Sep 2022
13F
Paradigm Biocapital Advisors LP
13F
Company
0.51%
634,211
$5,828,000 30 Sep 2022
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.48%
597,026
$5,487,000 30 Sep 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.48%
596,978
$5,486,000 30 Sep 2022
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.48%
596,531
$5,482,000 30 Sep 2022
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.45%
560,168
$5,137,000 30 Sep 2022
13F
BARCLAYS PLC
13F
Company
0.44%
540,582
$4,968,000 30 Sep 2022
13F
Bleichroeder LP
13F
Company
0.41%
512,500
$4,710,000 30 Sep 2022
13F
Eversept Partners, LP
13F
Company
0.1%
126,826
$1,165,531 30 Sep 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.08%
104,497
$960,000 30 Sep 2022
13F
Valeo Financial Advisors, LLC
13F
Company
0.06%
75,500
$694,000 30 Sep 2022
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.06%
73,752
$678,000 30 Sep 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.06%
73,274
$673,000 30 Sep 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
72,680
$668,000 30 Sep 2022
13F
Ensign Peak Advisors, Inc
13F
Company
0.06%
69,422
$638,000 30 Sep 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.04%
53,675
$493,000 30 Sep 2022
13F
BANK OF MONTREAL /CAN/
13F
Company
0.04%
48,100
$446,000 30 Sep 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.04%
46,308
$426,000 30 Sep 2022
13F
Paul F. Truex
3/4/5
Director
mixed-class rows
81,897
mixed-class rows
$383,548 31 May 2022
LMR Partners LLP
13F
Company
0.03%
38,495
$354,000 30 Sep 2022
13F
MARSHALL WACE, LLP
13F
Company
0.02%
30,898
$284,000 30 Sep 2022
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.02%
26,672
$245,000 30 Sep 2022
13F
Caption Management, LLC
13F
Company
0.02%
25,378
$233,000 30 Sep 2022
13F
STATE STREET CORP
13F
Company
0.02%
21,996
$202,000 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
17,576
$161,000 30 Sep 2022
13F
Engineers Gate Manager LP
13F
Company
0.01%
11,800
$108,000 30 Sep 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.01%
11,600
$107,000 30 Sep 2022
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.01%
11,499
$106,000 30 Sep 2022
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0.01%
10,500
$96,495 30 Sep 2022
13F
GROUP ONE TRADING LLC
13F
Company
0%
4,248
$39,000 30 Sep 2022
13F
Cutler Group LLC / CA
13F
Company
0%
3,937
$36,000 30 Sep 2022
13F
UBS Group AG
13F
Company
0%
3,320
$31,000 30 Sep 2022
13F
NATIONAL BANK OF CANADA /FI/
13F
Company
0%
2,880
$26,000 30 Sep 2022
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
2,602
$24,000 30 Sep 2022
13F
COWEN AND COMPANY, LLC
13F
Company
0.01%
14,000
$20,000 30 Sep 2022
13F
ROYAL BANK OF CANADA
13F
Company
0%
2,000
$18,000 30 Sep 2022
13F
CSS LLC/IL
13F
Company
0%
1,008
$9,000 30 Sep 2022
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0%
137
$1,000 30 Sep 2022
13F

Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares (MIST) as of Q4 2022

As of 31 Dec 2022, Milestone Pharmaceuticals Inc. - Common Shares (MIST) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,737,827 shares. The largest 10 holders included RTW INVESTMENTS, LP, GOLDMAN SACHS GROUP INC, VR Adviser, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., MORGAN STANLEY, Bleichroeder LP, BRAIDWELL LP, Point72 Asset Management, L.P., and CITADEL ADVISORS LLC. This page lists 55 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
43
Q4 2022 holders
55
Holder diff
12
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .